Skip to main content

Twelve-Month Outcomes From the OPuS-One Study: A Conversation With Dr Jason Levy

Twelve-Month Outcomes From the OPuS-One Study: A Conversation With Dr Jason Levy

This episode of IOL Radio features Dr Jason Levy, Interventional Radiologist at Northside Hospital in Atlanta, Georgia and lead investigator of the OPuS One trial, which studied the quality of life outcomes from a global, prospective, non-randomized, multicenter study of radiofrequency ablation using Medtronic’s OsteoCool system for the palliative treatment of patients with painful osseous metastases. Dr Levy recently presented outcomes out to 12 months at the 2021 meeting of the Society of Interventional Radiology.

Back to Top